Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1993 Mar;71(3):233-8.
doi: 10.1007/BF00180107.

Xanthoma disseminatum: a rare normolipemic xanthomatosis

Affiliations
Case Reports

Xanthoma disseminatum: a rare normolipemic xanthomatosis

N Weiss et al. Clin Investig. 1993 Mar.

Abstract

Xanthoma disseminatum (XD) is a rare benign histiocytic disorder with extensive cutaneous and mucous membrane xanthomas in normolipemic patients. We describe the 9-year course of a 25-year-old white man who presented with multiple brownish-reddish papulous skin tumors that developed over 3 years and remained relatively constant, with spontaneous regression and progression of individual lesions since. In addition, there was asymptomatic xanthomatous infiltration of the epipharnyx and symptomatic infiltration of the synovial membrane of the left knee joint leading to restriction of movement. Histologically, the corium was infiltrated by large lipid-storing macrophages, polynucleated histiocytic giant cells of the Touton and the foreign body type. Immunhistochemically, the lipid-storing cells could be classified as macrophage/monocyte derived cells distinctly different from Langerhans' cells without proliferative activity. The clinical picture and course as well as laboratory findings indicating normolipidemia made it possible to differentiate XD from other normolipemic xanthomatosis, especially juvenile xanthogranuloma, eruptive histiocytoma, and histiocytosis X. The etiology of XD is still unknown. It is possible to differentiate xanthoma disseminatum from malignant histiocytosis X by the clinical picture and immunhistochemical studies. Thus it is no longer justified to administer cytostatic treatment for this disorder.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Pediatr Hematol Oncol. 1988 Fall;10(3):252-7 - PubMed
    1. J Clin Invest. 1989 Mar;83(3):796-802 - PubMed
    1. Medicine (Baltimore). 1981 Sep;60(5):311-38 - PubMed
    1. Arch Dermatol. 1985 Oct;121(10):1313-7 - PubMed
    1. Nutr Metab. 1973;15(1):107-18 - PubMed

Publication types